MAGNE B6

This brand name is authorized in Estonia, France, Lithuania, Romania.

Active ingredients

The drug MAGNE B6 contains a combination of these active pharmaceutical ingredients (APIs):

`1`	Magnesium lactate UNII `IRT310VU4Z` - MAGNESIUM LACTATE DIHYDRATE
	Read more about Magnesium lactate
`2`	Pyridoxine UNII `68Y4CF58BV` - PYRIDOXINE HYDROCHLORIDE
	Pyridoxine hydrochloride is Vitamin B6. It is converted to pyridoxal phosphate which is the co-enzyme for a variety of metabolic transformations. It is essential for human nutrition.
	Read more about Pyridoxine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A12CC30	Magnesium (different salts in combination)	A Alimentary tract and metabolism → A12 Mineral supplements → A12C Other mineral supplements → A12CC Magnesium
Discover more medicines within A12CC30

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1115211, 1816512
FR	Base de données publique des médicaments	68617360
LT	Valstybinė vaistų kontrolės tarnyba	1015401, 1016613, 1059250, 1064032, 1066398, 1089897
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W68125001, W68126001, W68126002, W68127001, W68127002, W68127003

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.